Literature DB >> 29472331

Complete Genome Sequence of Escherichia coli 81009, a Representative of the Sequence Type 131 C1-M27 Clade with a Multidrug-Resistant Phenotype.

Michele Mutti1, Ágnes Sonnevend2, Tibor Pál2, Sini Junttila3, Heinz Ekker4, Bence Galik3, Attila Gyenesei3, Gábor Nagy1, Eszter Nagy1, Valéria Szijártó5.   

Abstract

The sequence type 131 (ST131)-H30 clone is responsible for a significant proportion of multidrug-resistant extraintestinal Escherichia coli infections. Recently, the C1-M27 clade of ST131-H30, associated with blaCTX-M-27, has emerged. The complete genome sequence of E. coli isolate 81009 belonging to this clone, previously used during the development of ST131-specific monoclonal antibodies, is reported here.
Copyright © 2018 Mutti et al.

Entities:  

Year:  2018        PMID: 29472331      PMCID: PMC5823992          DOI: 10.1128/genomeA.00056-18

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Escherichia coli strain 81009 was isolated from the urine of a 76-year-old male patient treated at Tawam Hospital, Al Ain, United Arab Emirates (1), and has recently been deposited at the Polish Collection of Microorganisms (PCM-2857). This strain belongs to sequence type 131 (ST131) and expresses the O25b O-antigen (2). E. coli 81009 is resistant to monobactams, cephalosporins, streptomycin, and fluoroquinolones and carries the blaCTX-M-27 allele. The recently emerging ST131-H30 isolates expressing CTX-M-27 are considered to form a new clade (C1-M27) within this clone (3, 4). Genomic DNA of E. coli 81009 was extracted with the Genomic-tip 100/G kit and Genome buffer set (Qiagen) from bacteria grown in LB supplemented with 100 μg/ml ampicillin to mid-log phase (optical density at 600 nm [OD600], ∼0.5). The genomic material was sequenced on a PacBio RS II platform (Pacific Biosciences, USA) and with the Illumina HiSeq 2500 platform with a paired-end (PE) 125-bp read length (Illumina, The Netherlands). Hierarchical Genome Assembly Process 4 (HGAP4) (5) was used for de novo assembly of the PacBio reads, and Illumina short reads were aligned to the de novo assembled genome with the Burrows-Wheeler Alignment tool (BWA) (6), followed by indel realignment and base quality recalibration with Genome Analysis Toolkit (GATK) (7). Protein-coding genes were called with Prodigal within the Prokka annotation pipeline (8). Trusted protein sequences for the annotation step were obtained from E. coli ST131 EC958 (9). Additional coding and noncoding RNA genes, as well as signal peptides, were predicted by RNAmmer, ARAGORN, SignalP, and Infernal within the Prokka annotation pipeline. The PlasmidFinder version 1.3 server (10) and ResFinder version 2.1 server (11) were used to identify plasmid repA genes and antibiotic resistance determinants. E. coli 81009 has a circular chromosome of 5,012,084 bp and one plasmid (pEC-81009) with a length of 135,720 bp. The chromosome has a GC content of 50.8% and contains 4,987 predicted genes encoding 4,668 proteins and 319 RNAs (including 87 tRNAs, 22 rRNAs, and 1 transfer-messenger RNAs [tmRNAs]). A putative function was assigned to 91.7% of the protein-coding genes. The extraintestinal pathogen designation of E. coli 81009 was supported by an array of virulence determinants identified in silico (12), including those involved in adhesion (upaB, crl, csgA, fimH, and iha), biofilm formation (bscA, agn43, and F9 fimbriae), survival in body fluids (iss and gad), and toxin production (senB and sat). E. coli 81009 was also shown to carry the H30 allele of the fimH gene. Additionally, an 11.8-kb region (M27PP1) specific to the C1-M27 clade of the H30 subclone (4) was identified, confirming that strain 81009 belongs to the C1-M27 clade. Plasmid pEC-81009 was found to belong to the IncFII-FIA-FIB group by in silico replicon typing (10). Among the 160 predicted genes carried on this plasmid, toxin/antitoxin systems (Phd/Doc, CcdBA, and Kid/Kis) and genes encoding resistance to aminoglycosides (aadA5, strA, and strB), sulfonamide (sul1 and sul2), tetracycline [tet(A)], macrolides (mphA), trimethoprim (dfrA17), and the extended-spectrum β-lactamase (ESBL) gene blaCTX-M-27 were identified. The availability of E. coli 81009 in a public repository and its well-characterized phenotype and genotype make it a suitable model organism for studying the ST131 C1-M27 clade.

Accession number(s).

The complete sequences of the chromosome and plasmid of E. coli 81009 have been deposited in GenBank under accession numbers CP021179 and CP021180, respectively.
  12 in total

1.  The rapidly emerging ESBL-producing Escherichia coli O25-ST131 clone carries LPS core synthesis genes of the K-12 type.

Authors:  Valéria Szijártó; Tibor Pal; Gabor Nagy; Eszter Nagy; Akela Ghazawi; Mohammed al-Haj; Sylvia El Kurdi; Agnes Sonnevend
Journal:  FEMS Microbiol Lett       Date:  2012-05-21       Impact factor: 2.742

2.  The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data.

Authors:  Aaron McKenna; Matthew Hanna; Eric Banks; Andrey Sivachenko; Kristian Cibulskis; Andrew Kernytsky; Kiran Garimella; David Altshuler; Stacey Gabriel; Mark Daly; Mark A DePristo
Journal:  Genome Res       Date:  2010-07-19       Impact factor: 9.043

3.  Nonhybrid, finished microbial genome assemblies from long-read SMRT sequencing data.

Authors:  Chen-Shan Chin; David H Alexander; Patrick Marks; Aaron A Klammer; James Drake; Cheryl Heiner; Alicia Clum; Alex Copeland; John Huddleston; Evan E Eichler; Stephen W Turner; Jonas Korlach
Journal:  Nat Methods       Date:  2013-05-05       Impact factor: 28.547

4.  Prokka: rapid prokaryotic genome annotation.

Authors:  Torsten Seemann
Journal:  Bioinformatics       Date:  2014-03-18       Impact factor: 6.937

5.  In silico detection and typing of plasmids using PlasmidFinder and plasmid multilocus sequence typing.

Authors:  Alessandra Carattoli; Ea Zankari; Aurora García-Fernández; Mette Voldby Larsen; Ole Lund; Laura Villa; Frank Møller Aarestrup; Henrik Hasman
Journal:  Antimicrob Agents Chemother       Date:  2014-04-28       Impact factor: 5.191

6.  Isolation and molecular characterization of nalidixic acid-resistant extraintestinal pathogenic Escherichia coli from retail chicken products.

Authors:  James R Johnson; Andrew C Murray; Abby Gajewski; Maureen Sullivan; Paula Snippes; Michael A Kuskowski; Kirk E Smith
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

7.  Identification of acquired antimicrobial resistance genes.

Authors:  Ea Zankari; Henrik Hasman; Salvatore Cosentino; Martin Vestergaard; Simon Rasmussen; Ole Lund; Frank M Aarestrup; Mette Voldby Larsen
Journal:  J Antimicrob Chemother       Date:  2012-07-10       Impact factor: 5.790

8.  The complete genome sequence of Escherichia coli EC958: a high quality reference sequence for the globally disseminated multidrug resistant E. coli O25b:H4-ST131 clone.

Authors:  Brian M Forde; Nouri L Ben Zakour; Mitchell Stanton-Cook; Minh-Duy Phan; Makrina Totsika; Kate M Peters; Kok Gan Chan; Mark A Schembri; Mathew Upton; Scott A Beatson
Journal:  PLoS One       Date:  2014-08-15       Impact factor: 3.240

9.  Global Escherichia coli Sequence Type 131 Clade with blaCTX-M-27 Gene.

Authors:  Yasufumi Matsumura; Johann D D Pitout; Ryota Gomi; Tomonari Matsuda; Taro Noguchi; Masaki Yamamoto; Gisele Peirano; Rebekah DeVinney; Patricia A Bradford; Mary R Motyl; Michio Tanaka; Miki Nagao; Shunji Takakura; Satoshi Ichiyama
Journal:  Emerg Infect Dis       Date:  2016-11       Impact factor: 6.883

10.  CTX-M-27-Producing Escherichia coli of Sequence Type 131 and Clade C1-M27, France.

Authors:  André Birgy; Philippe Bidet; Corinne Levy; Elsa Sobral; Robert Cohen; Stéphane Bonacorsi
Journal:  Emerg Infect Dis       Date:  2017-05       Impact factor: 6.883

View more
  5 in total

1.  Characterization of bla CTX-M-27/F1:A2:B20 Plasmids Harbored by Escherichia coli Sequence Type 131 Sublineage C1/H30R Isolates Spreading among Elderly Japanese in Nonacute-Care Settings.

Authors:  Nao Matsuo; Rina Nonogaki; Michiko Hayashi; Jun-Ichi Wachino; Masahiro Suzuki; Yoshichika Arakawa; Kumiko Kawamura
Journal:  Antimicrob Agents Chemother       Date:  2020-04-21       Impact factor: 5.191

2.  A New Tool for Complement Research: In vitro Reconstituted Human Classical Complement Pathway.

Authors:  Michele Mutti; Katharina Ramoni; Gábor Nagy; Eszter Nagy; Valéria Szijártó
Journal:  Front Immunol       Date:  2018-12-04       Impact factor: 7.561

3.  Population snapshot of the extended-spectrum β-lactamase-producing Escherichia coli invasive strains isolated from a Hungarian hospital.

Authors:  Kinga Tóth; Ákos Tóth; Katalin Kamotsay; Viktória Németh; Dóra Szabó
Journal:  Ann Clin Microbiol Antimicrob       Date:  2022-02-10       Impact factor: 3.944

Review 4.  Emerging Status of Multidrug-Resistant Bacteria and Fungi in the Arabian Peninsula.

Authors:  J Francis Borgio; Alia Saeed Rasdan; Bayan Sonbol; Galyah Alhamid; Noor B Almandil; Sayed AbdulAzeez
Journal:  Biology (Basel)       Date:  2021-11-06

Review 5.  Understanding the Epidemiology of Multi-Drug Resistant Gram-Negative Bacilli in the Middle East Using a One Health Approach.

Authors:  Iman Dandachi; Amer Chaddad; Jason Hanna; Jessika Matta; Ziad Daoud
Journal:  Front Microbiol       Date:  2019-08-23       Impact factor: 5.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.